Biotechnology
AKRO
25.60
price up icon1.83%   0.46
pre-market  Pre-market:  25.98   0.38   +1.48%

Akero Therapeutics Inc (AKRO)
full-star
loading
Overview News Price History Option Chain Financials Why AKRO Down? Discussions Forecast

Why is Akero Therapeutics Inc (AKRO) Stock down?

We've noticed a 8.90% decline in Akero Therapeutics Inc (AKRO) stock during the 2025-01-13 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
10 Oct, 2023:

Akero Therapeutics Stock (AKRO) dropped by 62.61% from $48.54 to $18.15 in the trading on Tuesday October 10, 2023. The reason why AKRO stock down today is due to the 36-week analysis of a Phase 2b SYMMETRY study evaluating the efficacy and safety of its lead product candidate efruxifermin (EFX). EFX didn't meet the primary endpoint of the phase 2b study.

Similar to AKRO

biotechnology GMAB
$21.80
price up icon 4.81%
biotechnology INCY
$73.47
price up icon 2.14%
biotechnology SMMT
$22.10
price up icon 16.13%
biotechnology UTHR
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
biotechnology BNTX
$117.25
price up icon 4.75%
Open in Yahoo | Open in Google | Open in Finviz | Open in MarketWatch | Open in EDGAR | Open in Reuters
Cap:     |  Volume (24h):